This topic contains a solution. Click here to go to the answer

Author Question: ________ are frequently able to influence others' attitudes or behavior. (Read 106 times)

fagboi

  • Hero Member
  • *****
  • Posts: 535

Question 1

Which of the following is a new kind of avoidance group that has grown in popularity through the Web?
◦ Consumer tribes
◦ Virtual worlds
◦ Anti-brand communities
◦ Virtual communities of consumption

Question 2

________ are frequently able to influence others' attitudes or behavior.
◦ Opinion leaders
◦ Environmental cues
◦ Anti-brand communities
◦ All of the above


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by fagboi on Jun 4, 2019

amit

  • Sr. Member
  • ****
  • Posts: 364
Lorsum iprem. Lorsus sur ipci. Lorsem sur iprem. Lorsum sur ipdi, lorsem sur ipci. Lorsum sur iprium, valum sur ipci et, vala sur ipci. Lorsem sur ipci, lorsa sur iprem. Valus sur ipdi. Lorsus sur iprium nunc, valem sur iprium. Valem sur ipdi. Lorsa sur iprium. Lorsum sur iprium. Valem sur ipdi. Vala sur ipdi nunc, valem sur ipdi, valum sur ipdi, lorsem sur ipdi, vala sur ipdi. Valem sur iprem nunc, lorsa sur iprium. Valum sur ipdi et, lorsus sur ipci. Valem sur iprem. Valem sur ipci. Lorsa sur iprium. Lorsem sur ipci, valus sur iprem. Lorsem sur iprem nunc, valus sur iprium.
Answer Preview
Only 55% of students answer this correctly



fagboi

  • Hero Member
  • *****
  • Posts: 535

amit

  • Sr. Member
  • ****
  • Posts: 364
Great! Please up vote :D



 

Did you know?

The FDA recognizes 118 routes of administration.

Did you know?

Excessive alcohol use costs the country approximately $235 billion every year.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

The horizontal fraction bar was introduced by the Arabs.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library